title: WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancer.
abstract: In a majority of cases, colorectal cancer is initiated by aberrant activation of the WNT signaling pathway. Mutation of the genes encoding the WNT signaling components adenomatous polyposis coli or β-catenin causes constitutively active β-catenin/TCF-mediated transcription, driving the transformation of intestinal crypts to cancer precursor lesions, called dysplastic aberrant crypt foci. Deregulated apoptosis is a hallmark of adenomatous colon tissue. However, the contribution of WNT signaling to this process is not fully understood. We addressed this role by analyzing the rate of epithelial apoptosis in aberrant crypts and adenomas of the Apc(Min/+) mouse model. In comparison with normal crypts and adenomas, aberrant crypts displayed a dramatically increased rate of apoptotic cell death. Expression profiling of apoptosis-related genes along the crypt-villus axis and in Apc mutant adenomas revealed increased expression of two pro-apoptotic Bcl-2 family members in intestinal adenomas, Bok and Bax. Analysis of the colon of familial adenomatous polyposis (FAP) patients along the crypt-to-surface axis, and of dysplastic crypts, corroborated this expression pattern. Disruption of β-catenin/TCF-4-mediated signaling in the colorectal cancer cell line Ls174T significantly decreased BOK and BAX expression, confirming WNT-dependent regulation in intestinal epithelial cells. Our results suggest a feedback mechanism by which uncontrolled epithelial cell proliferation in the stem cell compartment can be counterbalanced by an increased propensity to undergo cell death.
authors.affiliation: Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands.
authors.forename: Jurrit
authors.initials: J
authors.lastname: Zeilstra
authors.forename: Sander P J
authors.initials: SP
authors.lastname: Joosten
authors.forename: Felix M
authors.initials: FM
authors.lastname: Wensveen
authors.forename: Mark C
authors.initials: MC
authors.lastname: Dessing
authors.forename: Denise M
authors.initials: DM
authors.lastname: Schütze
authors.forename: Eric
authors.initials: E
authors.lastname: Eldering
authors.forename: Marcel
authors.initials: M
authors.lastname: Spaargaren
authors.forename: Steven T
authors.initials: ST
authors.lastname: Pals
mesh_terms: D000236:Adenoma / Q000235:genetics / Q000378:metabolism*; D000328:Adult; D000818:Animals; D017209:Apoptosis; D049109:Cell Proliferation; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007414:Intestinal Neoplasms / Q000235:genetics / Q000378:metabolism*; D008297:Male; D051379:Mice; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis* / Q000235:genetics; D015398:Signal Transduction; D051153:Wnt Proteins / Q000235:genetics / Q000378:metabolism*; D055815:Young Adult; D051028:bcl-2-Associated X Protein / Q000096:biosynthesis* / Q000235:genetics
chemical_list: C503049:BOK protein, human; D019253:Proto-Oncogene Proteins c-bcl-2; D051153:Wnt Proteins; D051028:bcl-2-Associated X Protein